ZMYM2 and cancer: As highlighted by Mas-Ponte and Supek [76], APOBEC/AID driven mutations tend to be directed towards early-replicating, gene-rich regions of the genome, inducing deleterious events on several genes including ZMYM2, which our pan-cancer model has linked with G0 arrest.